Annual Shareholders Equity
$266.97 M
+$78.20 M+41.42%
31 December 2023
Summary:
Acumen Pharmaceuticals annual stockholders equity is currently $266.97 million, with the most recent change of +$78.20 million (+41.42%) on 31 December 2023. During the last 3 years, it has risen by +$285.56 million (+1536.03%). ABOS annual shareholders equity is now at all-time high.ABOS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$217.20 M
-$26.75 M-10.96%
30 September 2024
Summary:
Acumen Pharmaceuticals quarterly stockholders equity is currently $217.20 million, with the most recent change of -$26.75 million (-10.96%) on 30 September 2024. Over the past year, it has dropped by -$63.07 million (-22.50%). ABOS quarterly shareholders equity is now -22.50% below its all-time high of $280.27 million, reached on 30 September 2023.ABOS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABOS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +41.4% | -22.5% |
| 3 y3 years | +1536.0% | -6.9% |
| 5 y5 years | - | - |
ABOS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +1536.0% | -22.5% | +28.6% |
| 5 y | 5 years | at high | +1536.0% | -22.5% | +304.8% |
| alltime | all time | at high | +1536.0% | -22.5% | +304.8% |
Acumen Pharmaceuticals Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $217.20 M(-11.0%) |
| June 2024 | - | $243.95 M(-6.9%) |
| Mar 2024 | - | $262.03 M(-1.8%) |
| Dec 2023 | $266.97 M(+41.4%) | $266.97 M(-4.7%) |
| Sept 2023 | - | $280.27 M(+66.0%) |
| June 2023 | - | $168.87 M(-5.7%) |
| Mar 2023 | - | $179.09 M(-5.1%) |
| Dec 2022 | $188.78 M | $188.78 M(-4.0%) |
| Sept 2022 | - | $196.65 M(-4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $206.52 M(-4.4%) |
| Mar 2022 | - | $216.09 M(-4.0%) |
| Dec 2021 | $225.18 M(-1311.2%) | $225.18 M(-3.5%) |
| Sept 2021 | - | $233.36 M(-320.0%) |
| June 2021 | - | -$106.08 M(+133.3%) |
| Mar 2021 | - | -$45.46 M(+144.5%) |
| Dec 2020 | -$18.59 M(+62.8%) | - |
| Dec 2020 | - | -$18.59 M |
| Dec 2019 | -$11.42 M | - |
FAQ
- What is Acumen Pharmaceuticals annual stockholders equity?
- What is the all time high annual shareholders equity for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals annual shareholders equity year-on-year change?
- What is Acumen Pharmaceuticals quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Acumen Pharmaceuticals?
- What is Acumen Pharmaceuticals quarterly shareholders equity year-on-year change?
What is Acumen Pharmaceuticals annual stockholders equity?
The current annual shareholders equity of ABOS is $266.97 M
What is the all time high annual shareholders equity for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high annual stockholders equity is $266.97 M
What is Acumen Pharmaceuticals annual shareholders equity year-on-year change?
Over the past year, ABOS annual stockholders equity has changed by +$78.20 M (+41.42%)
What is Acumen Pharmaceuticals quarterly stockholders equity?
The current quarterly shareholders equity of ABOS is $217.20 M
What is the all time high quarterly shareholders equity for Acumen Pharmaceuticals?
Acumen Pharmaceuticals all-time high quarterly stockholders equity is $280.27 M
What is Acumen Pharmaceuticals quarterly shareholders equity year-on-year change?
Over the past year, ABOS quarterly stockholders equity has changed by -$63.07 M (-22.50%)